Oral‐lung microbiome interactions in lung diseases
Citations Over TimeTop 1% of 2020 papers
Abstract
The proximity and continuity of the oral cavity and the lower respiratory tract allows the oropharyngeal microbiome to be a major determinant of the lung microbiome. In addition, host-pathogen interactions related to the oropharyngeal microbiome or its metabolites could propagate systemic inflammation or modulate host defense mechanisms that could affect other organs, including the lung. There is increasing appreciation of the pathophysiologic significance of the lung microbiome, not only in the classical infection-related diseases, pneumonia, bronchiectasis, and cystic fibrosis, but also in chronic noninfectious lung diseases, such as chronic obstructive pulmonary disease, asthma, and pulmonary fibrosis. In this review, we will explore the relationship of the oral microbiome with lung diseases, such as pneumonia, chronic obstructive pulmonary disease, asthma, and cystic fibrosis.
Related Papers
- → Alpha 1-antitrypsin deficiency: evaluation of bronchiectasis with CT.(1996)136 cited
- → Reversible bronchial dilatation in adults(2021)9 cited
- → Bronchiectasis in hypogammaglobulinaemia — A computed tomography assessment(1991)64 cited
- → Correlation Between Alpha-1-Antitrypsin Levels and Bronchiectasis in Humoral Immunodeficiency Patients Receiving Gammaglobulin Infusions(2017)1 cited
- → Bronchiectasis In Specific Antibody Deficiency (SAD): More Common Than Previously Thought(2019)